Skip to main content

Consider Jakafi®…

Written by patrippon on .

When

03/30/21    
6:30 pm - 7:30 pm
Download ICS Google Calendar iCalendar Office 365 Outlook Live

Webcast Event

Consider Jakafi® (ruxolitinib) At the First Sign of Steroid-Refractory Acute GVHD

 

Featured Speaker:
Jonathan Abbas, MD
Tennessee Oncology
Nashville, TN

Register here.

You may also register by contacting your Incyte Representative Carole Yates at (415) 518-3889 or cyates@incyte.com with the following information: name, title/ degree, state(s) and state license number(s), affiliation, address, phone and email.